Navigation Links
Chemists unlock potential target for drug development
Date:1/19/2012

EAST LANSING, Mich. -- A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists.

A team led by Dana Spence of MSU's Department of Chemistry has revealed a way to isolate and test the receptor known as P2X1. By creating a new, simple method to study it after blood is drawn, the team has unlocked a potential new drug target for many diseases that impact red blood cells, such as diabetes, hypertension and cystic fibrosis.

Researchers can evaluate the receptor not only in developing new drugs but also re-testing existing medications that could work now by attaching to the receptor.

"Scientists are always looking for new 'druggable' receptors in the human body," Spence said. "This receptor, P2X1, has long been viewed as not important in platelets; our studies show that is not necessarily true. The receptor is very active; you just need to be careful in working with it."

The research is published in the current issue of Analytical Methods, a journal from the Royal Society of Chemistry in London.

The main job of platelets is to help prevent bleeding via clotting, Spence said. They work by getting sticky in the bloodstream, but the problem with some diseases such as diabetes or sickle-cell anemia is that the platelets get sticky even when they shouldn't, preventing proper blood flow and blocking vessels.

Platelets are activated when their receptors are "turned on"; currently, researchers have always focused on the P2Y receptor, which is easily studied. On the other hand, the P2X1 receptor was not thought to play a major role in platelet activation, and it proved very troublesome to study since it became desensitized once blood is drawn from the body, Spence said.

Though scientists tried a pair of methods to get around that issue by using different additives or enzymes the results did not prove fruitful in studying the receptor.

What Spence and his team found is that by adding a simple molecule called NF449 originally thought to block the receptor they were able to activate the P2X1 receptor in platelets after a blood draw.

"We have discovered a way to prepare and handle platelets so that we can study the receptor authentically," he said. "This research opens up new avenues of study and will allow researchers and pharmaceutical companies to re-appraise this receptor as a druggable target."


'/>"/>
Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related biology news :

1. Chemists reveal the force within you
2. Clemson University biochemists identify new genetic code repair tool
3. Tel Aviv Universitys Sackler Prizes awarded to 2 North American chemists
4. K-State chemists biosensor may improve food, water safety and cancer detection
5. UCSB chemists make discovery that may lead to drug treatment possibilities for Alzheimers
6. Chemists turn gold to purple -- on purpose
7. Chemists document workings of key staph enzyme -- and how to block it
8. US launches International Year of Chemistry Feb. 1 with panel of world-renowned chemists
9. Chemists concoct new agents to easily study critical cell proteins
10. Team of chemists produces biodiesel at their university, using used cooking oil as a basis
11. Brown University chemists simplify biodiesel conversion
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemists unlock potential target for drug development
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):
(Date:7/14/2017)... ... July 14, 2017 , ... Diagenode ... of proteins to clean peptides for mass spectrometry (MS) analysis combining the PreOmics ... PreOmics iST Kit is based on proprietary technology that contains optimized buffer systems ...
(Date:7/13/2017)... ... July 13, 2017 , ... ... Specialty Pharmacy. URAC is the independent leader in promoting healthcare quality through accreditation, ... commitment to quality care, improved processes and better patient outcomes. , “Achieving ...
(Date:7/13/2017)... ... July 13, 2017 , ... FireflySci Inc. started manufacturing calibration ... seven years and now they are home to a tremendous line of certified ... and resolution testing. , One mega advantage that FireflySci brings to ...
(Date:7/13/2017)... , ... July 13, 2017 , ... ... programs at Philadelphia’s University City Science Center, Christopher Laing, MRCVS, Ph.D. has been ... Austin, Texas. Dr. Laing will become the first Executive Director at the ...
Breaking Biology Technology: